- Home
- PHAR vs CGNT Comparison
PHAR vs CGNT Comparison
Compare PHAR & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- CGNT
- Stock Information
- Founded
- PHAR 1988
- CGNT 2020
- Country
- PHAR Netherlands
- CGNT Israel
- Employees
- PHAR N/A
- CGNT N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- CGNT Computer Software: Prepackaged Software
- Sector
- PHAR Health Care
- CGNT Technology
- Exchange
- PHAR Nasdaq
- CGNT Nasdaq
- Market Cap
- PHAR 718.1M
- CGNT 669.2M
- IPO Year
- PHAR N/A
- CGNT N/A
- Fundamental
- Price
- PHAR $10.65
- CGNT $9.09
- Analyst Decision
- PHAR Strong Buy
- CGNT Hold
- Analyst Count
- PHAR 3
- CGNT 1
- Target Price
- PHAR $30.00
- CGNT N/A
- AVG Volume (30 Days)
- PHAR 4.4K
- CGNT 458.1K
- Earning Date
- PHAR 07-31-2025
- CGNT 06-11-2025
- Dividend Yield
- PHAR N/A
- CGNT N/A
- EPS Growth
- PHAR N/A
- CGNT N/A
- EPS
- PHAR N/A
- CGNT N/A
- Revenue
- PHAR $320,708,000.00
- CGNT $363,466,000.00
- Revenue This Year
- PHAR $13.31
- CGNT $14.94
- Revenue Next Year
- PHAR $7.68
- CGNT $9.57
- P/E Ratio
- PHAR N/A
- CGNT N/A
- Revenue Growth
- PHAR 24.13
- CGNT 12.58
- 52 Week Low
- PHAR $6.65
- CGNT $6.21
- 52 Week High
- PHAR $12.61
- CGNT $11.66
- Technical
- Relative Strength Index (RSI)
- PHAR 49.05
- CGNT 40.78
- Support Level
- PHAR $10.46
- CGNT $9.04
- Resistance Level
- PHAR $11.49
- CGNT $9.49
- Average True Range (ATR)
- PHAR 0.36
- CGNT 0.33
- MACD
- PHAR -0.12
- CGNT -0.03
- Stochastic Oscillator
- PHAR 31.46
- CGNT 36.87
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.